UPLYFT For Lymphoma Survivors

Clinical trial NCT05080166 · COMPLETED

Trial details

NCT number: NCT05080166
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Lymphoma Survivorship

Start date: 2022-02-08
Primary completion: 2026-07-17
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.